Jane Street Group LLC boosted its holdings in shares of Haleon plc (NYSE:HLN - Free Report) by 1,689.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 264,977 shares of the company's stock after purchasing an additional 250,169 shares during the period. Jane Street Group LLC's holdings in Haleon were worth $2,803,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in HLN. Fortitude Family Office LLC bought a new position in shares of Haleon in the third quarter valued at $28,000. Prospera Private Wealth LLC acquired a new stake in shares of Haleon during the third quarter worth $57,000. BOKF NA raised its position in shares of Haleon by 68.8% during the second quarter. BOKF NA now owns 6,972 shares of the company's stock worth $58,000 after purchasing an additional 2,842 shares during the period. Rothschild Investment LLC purchased a new stake in shares of Haleon during the second quarter valued at $60,000. Finally, Brown Brothers Harriman & Co. boosted its position in shares of Haleon by 21.4% in the 2nd quarter. Brown Brothers Harriman & Co. now owns 7,569 shares of the company's stock valued at $63,000 after purchasing an additional 1,334 shares during the period. 6.67% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
HLN has been the topic of several recent analyst reports. UBS Group upgraded Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. Morgan Stanley boosted their price target on shares of Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a report on Friday, September 20th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Haleon currently has an average rating of "Buy" and a consensus target price of $10.95.
Get Our Latest Report on HLN
Haleon Stock Down 0.1 %
Shares of HLN stock traded down $0.01 on Friday, reaching $9.69. 5,796,123 shares of the company's stock traded hands, compared to its average volume of 5,450,907. The company has a market capitalization of $43.86 billion, a P/E ratio of 28.50, a price-to-earnings-growth ratio of 2.95 and a beta of 0.28. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The business's 50 day moving average price is $9.71 and its two-hundred day moving average price is $9.57.
About Haleon
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Articles
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.